4.1 Article

The Longitudinal Course of Post-Stroke Apathy Over Five Years

期刊

出版社

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.neuropsych.12040080

关键词

-

资金

  1. Pfizer Australia
  2. Janssen Cilag Australia
  3. Lundbeck
  4. Novartis
  5. Eisai
  6. National Health and Medical Research Council, Australia
  7. Pfizer
  8. Astra Zeneca
  9. National Health and Medical Research Council Australia
  10. National Health and Medical Research Council of Australia [970922, 222842]

向作者/读者索取更多资源

The prevalence of apathy is high after stroke, but its subsequent course remains unclear. We sought to determine the longitudinal course and predictors of apathy after stroke. Eligible patients admitted after a stroke and healthy control participants who were rated at least once on the Apathy Evaluation Scale were assessed over 5 years. Rates and levels of apathy in patients rose over 5 years. Significant risk factors for apathy were dementia, interval cerebrovascular events, poor physical functioning, and high depression scores. Apathy is common after stroke and becomes more prevalent with time, especially in those who show evidence of cognitive and functional decline.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据